Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunjan L Shah

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Transplantation and Cellular Therapy|May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular TherapyCorrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Transplantation and Cellular Therapy|March 1, 2026
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell LymphomaMarina Gomez-Llobell, Roni Shouval, Samantha Brown, et al.
Blood Cancer Journal|August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphomaMichael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Blood Advances|June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplantSusan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Journal of Palliative Medicine|March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant RecipientsRichard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Transplantation and Cellular Therapy|March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent WavesMariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Nature Cancer|November 9, 2023
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimensFrancesco Maura, Eileen M Boyle, David Coffey, et al.
Cancer|August 30, 2022
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantationMichael Scordo, Gunjan L Shah, Peter A Adintori, et al.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Blood Advances|September 10, 2021
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCTRoni Shouval, Joshua A Fein, Christina Cho, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Transplantation and Cellular Therapy|May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular TherapyCorrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Transplantation and Cellular Therapy|March 1, 2026
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell LymphomaMarina Gomez-Llobell, Roni Shouval, Samantha Brown, et al.
Blood Cancer Journal|August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphomaMichael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Blood Advances|June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplantSusan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Journal of Palliative Medicine|March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant RecipientsRichard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Transplantation and Cellular Therapy|March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent WavesMariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Nature Cancer|November 9, 2023
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimensFrancesco Maura, Eileen M Boyle, David Coffey, et al.
Cancer|August 30, 2022
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantationMichael Scordo, Gunjan L Shah, Peter A Adintori, et al.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Blood Advances|September 10, 2021
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCTRoni Shouval, Joshua A Fein, Christina Cho, et al.
Pageof 13